67 related articles for article (PubMed ID: 12445374)
1. Edrecolomab (Panorex) as adjuvant therapy for stage II colon cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):16-7. PubMed ID: 12445374
[No Abstract] [Full Text] [Related]
2. Update of clinical trials with edrecolomab: a monoclonal antibody therapy for colorectal cancer.
Haller DG
Semin Oncol; 2001 Feb; 28(1 Suppl 1):25-30. PubMed ID: 11273586
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant therapy of colon carcinoma: results of two Intergroup Studies (INT-0035 and INT-0089), a study by the German Cancer Aid 17-1A Study Group and the IMPACT Study].
Petrasch S; Schmiegel W
Z Gastroenterol; 1997 Jan; 35(1):49-52. PubMed ID: 9123959
[No Abstract] [Full Text] [Related]
5. Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.
Chibaudel B; Tournigand C; André T; Larsen AK; de Gramont A
Clin Colorectal Cancer; 2010 Dec; 9(5):269-73. PubMed ID: 21208840
[TBL] [Abstract][Full Text] [Related]
6. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy of stage III colon cancer.
Benson AB
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
9. VICTOR spoiled?
Goldberg RM; Bertagnolli MM
J Clin Oncol; 2010 Oct; 28(30):4546-8. PubMed ID: 20837951
[No Abstract] [Full Text] [Related]
10. Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study.
Hartung G; Hofheinz RD; Dencausse Y; Sturm J; Kopp-Schneider A; Dietrich G; Fackler-Schwalbe I; Bornbusch D; Gonnermann M; Wojatschek C; Lindemann W; Eschenburg H; Jost K; Edler L; Hochhaus A; Queisser W
Onkologie; 2005 Jun; 28(6-7):347-50. PubMed ID: 15933423
[TBL] [Abstract][Full Text] [Related]
11. When wishful thinking leads to a misty-eyed appraisal: the story of the adjuvant colon cancer trials with edrecolomab.
Schmoll HJ; Arnold D
J Clin Oncol; 2009 Apr; 27(12):1926-9. PubMed ID: 19273695
[No Abstract] [Full Text] [Related]
12. [Adjuvant therapy of colorectal cancers].
Joensuu H; Kellokumpu I
Duodecim; 1997; 113(8):705-13. PubMed ID: 11466869
[No Abstract] [Full Text] [Related]
13. Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma.
Schwartzberg LS
Crit Rev Oncol Hematol; 2001 Oct; 40(1):17-24. PubMed ID: 11578913
[TBL] [Abstract][Full Text] [Related]
14. [The present situation regarding postoperative adjuvant chemotherapy].
Shimada R; Nozawa K; Watanabe T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1396-402. PubMed ID: 21918334
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.
Tejpar S; Saridaki Z; Delorenzi M; Bosman F; Roth AD
J Natl Cancer Inst; 2011 Jun; 103(11):841-4. PubMed ID: 21597023
[No Abstract] [Full Text] [Related]
17. [Tumor targeting in colon cancer. Antibody therapy--a new adjuvant application].
Chirurg; 1995 Jul; 66(7 Suppl):1-4. PubMed ID: 9131058
[No Abstract] [Full Text] [Related]
18. Optimal treatment of metastatic colorectal cancer.
Pessino A; Sobrero A
Expert Rev Anticancer Ther; 2006 May; 6(5):801-12. PubMed ID: 16759170
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
20. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
